Skip to main content

Table 3 Comparison of costs (direct and indirect) at 18 months for HbA1c tests - costs per patient (Australian dollars, calendar year 2006)

From: The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial

RESOURCES INTERVENTION (PoCT) N = 1182 CONTROL (Laboratory) N = 785 DIFFERENCE (INTERVENTION - CONTROL)
Direct Costs to the health care sector (95% CI) (95% CI) (95% CI)
Establishment costs in GP $114 $0* $114
Consumables & maintenance in GP $28 ($22, $31) $0* $28 ($22, $31)
Quality assurance & control in GP $29 $0* $29
HbA1c tests (100% MBS fee in GP, 85% MBS fee in pathology laboratory) $64 ($49, $65) $98 ($88, $107) -$34 (-$54, -$28)
   Sub total cost of actual test $235 ($184, $290) $98 ($88, $107) $137 ($84, $194)
GP consultations $579 ($515, $659) $560 ($502, $618) $18 (-$69, $112)
Hospital admissions $171 (-$181, $662) $506 (-$137, $1,241) -$334 (-$1,131, $460)
Emergency Dept visits $8 ($3, $13) $8 ($2, $13) -$1 (-$8, $7)
Specialist consultations $173 ($163, $183) $169 ($157, $180) $4 (-$11, $20)
Allied health visits $221 ($195, $253) $232 ($188, $282) -$11 (-$72, $47)
Pharmaceuticals $2,249 ($1,889, $2,555) $2,032 ($1,859, $2,586) $217 (-$280, $253)
   Subtotal direct costs to healthcare sector $3,636 ($3,019, $4,149) $3,606 ($2,902, $4,563) $30 (-$988, $673)
Direct Costs to the patients and families    
Copayment for GP consultations and pharmaceuticals $4 ($4, $6) $4 ($2, $6) $0 (-$2, $4)
Patient travel costs $12 ($10, $14) $28 ($23, $33) -$16 (-$22, -$11)
   Subtotal direct costs to patients and families $16 ($15, $19) $32 ($28, $39) -$16 (-$22, -$10)
Indirect Costs    
   Time seeking healthcare $23 ($22, $25) $34 ($32, $37) -$11 (-$14, -$8)
Total costs (both sectors)    
   Total $3,676 ($3,062, $4,191) $3,672 ($2,972, $4,628) $4 (-$1,103, $642)
  1. Note: totals not exact due to rounding
  2. * For the control group these items are included in the MBS fee for the laboratory